According to the research report, the global cell lysis & disruption market size is expected to touch USD 7.1Billion by 2030, from USD 3.7 Billion in 2020, growing with a significant CAGR of 3.7 % from 2021 to 2030.
The cell lysis & disruption report offers a comprehensive study of the
current state expected at the major drivers, market strategies, and key
vendors’ growth. The report presents energetic visions to conclude and study
the market size, market hopes, and competitive surroundings. The research also
focuses on the important achievements of the market, research & development,
and regional growth of the leading competitors operating in the market. The
current trends of the global cell lysis & disruption in conjunction with the geographical landscape
of this vertical have also been included in this report.
The report offers intricate dynamics about
different aspects of the global cell lysis & disruption market, which aids companies operating in the
market in making strategic development decisions. The study also elaborates on
significant changes that are highly anticipated to configure growth of the global
cell lysis & disruption during the
forecast period. It also includes a key indicator assessment that highlights
growth prospects of this market and estimates statistics related to growth of
the market in terms of value (US$ Mn) and volume (tons).
Sample
Link @ https://www.precedenceresearch.com/sample/1292
| Report Coverage | Details |
| Market Size By 2030 | US$ 7.1 Billion |
| Growth Rate From 2021 to 2030 | CAGR of 6.7% |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| By Product |
|
| By Application |
|
This study covers a detailed segmentation
of the global cell lysis & disruption market, along with key information and a
competition outlook. The report mentions company profiles of players that are
currently dominating the global cell lysis & disruption market, wherein various developments,
expansions, and winning strategies practiced and implemented by leading players
have been presented in detail.
Key Players
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Qiagen NV
- Parr Instrument Company
- Covaris Inc.
- Merck KGaA
- Bio-Rad Laboratories
- F. Hoffmann-La Roche Ltd.
- Claremont BioSolutions
- Becton Dickinson & Company
Market Segmentation
- Instruments
- Reagents
By Cell Type
- Bacteria Cells
- Mammalian Cells
- Plant Cells
- Yeast/Fungi/Algae
By Application
- Cell Organelle Isolation
- Protein Isolation
- Downstream Processing
- Nucleic Acid Isolation
By End Use
- Hospitals and Diagnostic Laboratories
- Cell Banks
- Academic and Research Institutions
- Pharma & Biotechnology Companies
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Research Methodology
The research methodology adopted by
analysts for compiling the global cell lysis & disruption report is based on detailed primary as well as
secondary research. With the help of in-depth insights of the market-affiliated
information that is obtained and legitimated by market-admissible resources,
analysts have offered riveting observations and authentic forecasts for the
global market.
During the primary research phase, analysts
interviewed market stakeholders, investors, brand managers, vice presidents,
and sales and marketing managers. Based on data obtained through interviews of
genuine resources, analysts have emphasized the changing scenario of the global
market.
For secondary research, analysts
scrutinized numerous annual report publications, white papers, market
association publications, and company websites to obtain the necessary
understanding of the global cell lysis & disruption market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cell Lysis & Disruption Market, By Product
7.1. Cell Lysis & Disruption Market, by Product Type, 2021-2030
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Reagents
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Cell Lysis & Disruption Market, By Application
8.1. Cell Lysis & Disruption Market, by Application, 2021-2030
8.1.1. Cell Organelle Isolation
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Protein Isolation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Downstream Processing
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Nucleic Acid Isolation
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell Lysis & Disruption Market, By Cell Type
9.1. Cell Lysis & Disruption Market, by Cell Type, 2021-2030
9.1.1. Bacteria Cells
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Mammalian Cells
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Plant Cells
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Yeast/Fungi/Algae
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell Lysis & Disruption Market, By End Use Type
10.1. Cell Lysis & Disruption Market, by End Use Type, 2021-2030
10.1.1. End Use
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cell Banks
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Academic and Research Institutions
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Pharma & Biotechnology Companies
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell Lysis & Disruption Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Danaher Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Qiagen NV
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Parr Instrument Company
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Covaris Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Merck KGaA
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. F. Hoffmann-La Roche Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Claremont BioSolutions
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Becton Dickinson & Company
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1
774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments